site stats

Jcog9702

Web26 gen 2024 · A previous phase III clinical trial (JCOG9702) indicated that carboplatin and etoposide (CE) combination therapy can be safe and effective for ES-SCLC patients with … Web1 apr 2010 · introduction. Lung cancer is currently a leading cause of cancer death in many countries [1, 2], and small-cell lung cancer (SCLC) accounts for 15%–20% of all lung cancer cases.Over 50% of patients newly diagnosed as SCLC are >70 years old, and the number of elderly patients is expected to increase because the geriatric population is also rapidly …

Efficacy and safety of carboplatin and etoposide in older extensive ...

WebView 46 photos of this 3 bed, 2 bath, 1352 sqft. single family home located at 4970 102nd Ave, Grand Junction, MI 49056 on sale now for $169900. WebJCOG9702 Lung SCLC PS0-2 ≥ 70 CBDCA＋ VP-16 CDDP＋ VP-16 OS Completed Br J Cancer 2007 JCOG0207 Lung NSCLC PS0-1 ≥ 70 DOC Weekly DOC+CDDP Weekly OS Completed JJCO 2015 JCOG0301 Lung NSCLC PS0-2 ≥ 71 RT alone CBDCA＋ RT OS Completed Lancet Oncol 2012 JCOG0803 /WJOG4307L Lung NSCLC PS0-1 ≥ 70 DOC … helloween in the middle of a heartbeat lyrics https://easthonest.com

Carboplatin- or Cisplatin-Based Chemotherapy in First …

Web2 feb 2024 · A phase III trial (JCOG9702) of carboplatin and etoposide versus split cisplatin (cisplatin administered in divided doses) and etoposide in patients aged ≥70 (PS, 0‑2) and <70 (PS, 3) years showed more grade 3/4 thrombocytopenia in patients given carboplatin and etoposide (56 vs. 16%, respectively; WebJCOG9702 (phaseIII）. 高齢者もしくは予後不良の未治療肺小細胞癌に対するCBDCA+VP-16併用療法とCDDP+VP-16併用療法の有効性を評価する。. 高齢者肺小細胞癌に対する標準的治療はいまだ確立されていない。. JCOG肺がん内科グループでは、平成7年4月から高齢 … Web17 ott 2024 · Another trial (JCOG9702) that compared CDDP+ETP and CBDCA+ETP did not indicate a large difference in the efficacy endpoint between the two arms (HRos 1.04, HRpfs 0.92, and ORrr 1.0), using CDDP+ETP as reference. 26 However, this trial recruited only elderly Japanese patients; therefore, it remains unclear whether the results can be … lakes is a reservoir created by dams

JCOG9702

Category:Randomized phase III trial of carboplatin(C) plus etoposide (E) vs ...

Tags:Jcog9702

Jcog9702

(PDF) 1476PFINAL RESULTS OF A RANDOMIZED PHASE 2 STUDY …

Web17 ott 2024 · Another trial (JCOG9702) that compared CDDP+ETP and CBDCA+ETP did not indicate a large difference in the efficacy endpoint between the two arms (HRos 1.04, HRpfs 0.92, and ORrr 1.0), using CDDP+ETP as reference. 26 However, this trial recruited only elderly Japanese patients; therefore, it remains unclear whether the results can be … Web25 set 2024 · Conclusions. The addition of atezolizumab to chemotherapy in the first-line treatment of extensive-stage small-cell lung cancer resulted in significantly longer overall …

Jcog9702

Did you know?

WebNational Center for Biotechnology Information Web2 feb 2024 · A phase III trial (JCOG9702) of carboplatin and etoposide versus split cisplatin (cisplatin administered in divided doses) and etoposide in patients aged ≥70 (PS, 0‑2) …

Web特に、全身状態が不良な症例や高齢者においては、jcog9702の結果からシスプラチン・エトポシド併用療法と変わらない有効性が示されており、より身体的負担の少ない本治療法が薦められる。副作用では、血小板減少などの骨髄抑制に特に注意が必要である。 http://www.jcog.jp/document/s_9702.pdf

Web2 apr 2012 · Four eligible trials with 663 patients (328 assigned to cisplatin and 335 to carboplatin) were included in the analysis. Median OS was 9.6 months for cisplatin and … Web16 lug 2007 · We compared the efficacy and the safety of a carboplatin plus etoposide regimen (CE) vs split doses of cisplatin plus etoposide (SPE) in elderly or poor-risk …

Web16 ago 2024 · In Japan, a phase III study (JCOG9702 study) compared CBDCA + ETP and split CDDP + ETP in older patients (≥70 years) with ED-SCLC, and although …

Web20 mag 2014 · 7521 Background: Cisplatin-based regimens are standard first-line chemotherapy for ED-SCLC. In patients unfit for cisplatin due to advanced age or poor performance status (PS), carboplatin plus etoposide (CE) is as effective as cisplatin plus etoposide (JCOG9702 trial). Carboplatin plus irinotecan (CI) and carboplatin plus … lake siskiyou campground and resortWeb1 ott 2024 · In patients (pts) unfit for cisplatin due to advanced age or poor performance status (PS), carboplatin plus etoposide (CE) is as effective as cisplatin plus etoposide (JCOG9702 trial), although ... helloween i want out liveWeb2 feb 2024 · A phase III trial (JCOG9702) of carboplatin and etoposide versus split cisplatin (cisplatin administered in divided doses) and etoposide in patients aged ≥70 (PS, 0–2) and <70 (PS, 3) years showed more grade 3/4 thrombocytopenia in patients given carboplatin and etoposide (56 vs. 16%, respectively; P<0.01), but ORR (73 vs. 73%, respectively ... helloween i want out youtubelake siskiyou beach and campWebIn patients unfit for cisplatin due to advanced age or poor performance status (PS), carboplatin plus etoposide (CE) is as effective as cisplatin plus etoposide (JCOG9702 trial). Carboplatin plus irinotecan (CI) and carboplatin plus amrubicin (CA) are promising new carboplatin-based regimens identified in our previous studies (NJLCG0405 and … helloween judas lyricsWeb13 dic 2013 · In the JCOG9702 , the percentages of patients who have received three and four courses of CE regimen were 69 and 63%, respectively. In this study, we considered … helloween keeper of the seven keys 1WebJCOG9702 (phaseIII）. 高齢者もしくは予後不良の未治療肺小細胞癌に対するCBDCA+VP-16併用療法とCDDP+VP-16併用療法の有効性を評価する。. 高齢者肺小細胞癌に対す … helloween just a little sign